Choshi, Japan

Kaori Tanabe


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kaori Tanabe

Introduction

Kaori Tanabe is a notable inventor based in Choshi, Japan. She has made significant contributions to the field of enzymatic synthesis, particularly in the development of cyclic di-GMP. With a total of 2 patents to her name, her work has garnered attention for its practical applications and innovative methodologies.

Latest Patents

One of her latest patents is a practical method for enzymatically synthesizing cyclic di-GMP. This invention provides an efficient approach to producing c-di-GMP with excellent productivity. The diguanylate cyclase involved in this process exhibits several key physical and chemical characteristics. These include catalytic action on the reaction '2 GTP → c-di-GMP', a molecular weight of 19800 ± 2000, an optimum pH range of 7.3 to 9.4, and an optimum temperature range of 35 to 60 °C. Additionally, it demonstrates thermal stability, maintaining 90% or higher activity after being heated for 60 minutes at 50 °C and pH 7.8. The diguanylate cyclase also possesses the GGDEF domain while lacking the amino acid sequence KXXD in the i-site.

Career Highlights

Kaori Tanabe is currently employed at Yamasa Corporation, where she continues to innovate and contribute to her field. Her work at the company has allowed her to explore various aspects of enzymatic processes and their applications in biotechnology.

Collaborations

Kaori collaborates with Kazuya Ishige, a talented woman in her field. Together, they work on advancing their research and developing new methodologies that can benefit various industries.

Conclusion

Kaori Tanabe's contributions to the field of enzymatic synthesis, particularly her work on cyclic di-GMP, highlight her innovative spirit and dedication to advancing scientific knowledge. Her patents reflect her commitment to practical solutions in biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…